Phenotype of the lymphoma cell lines
| Receptor . | 164T2 . | 164T2S11 . |
|---|---|---|
| CD3ε | + | + |
| CD4 | − | − |
| CD8 | − | − |
| CD11a/CD18 (LFA-1) | + | + |
| CD29/CD49d (VLA-4) | − | − |
| CD29/CD49e (VLA-5) | − | − |
| CD31 | + | + |
| CD44 | − | − |
| CD54 (ICAM-1) | + | + |
| CD62L (l-selectin) | + | + |
| CD90 (Thy-1.2) | + | + |
| CD102 (ICAM-2) | + | + |
| CD106 (VCAM-1) | − | − |
| gp70 | + | + |
| αβTcR | + | + |
| TL | + | + |
| Receptor . | 164T2 . | 164T2S11 . |
|---|---|---|
| CD3ε | + | + |
| CD4 | − | − |
| CD8 | − | − |
| CD11a/CD18 (LFA-1) | + | + |
| CD29/CD49d (VLA-4) | − | − |
| CD29/CD49e (VLA-5) | − | − |
| CD31 | + | + |
| CD44 | − | − |
| CD54 (ICAM-1) | + | + |
| CD62L (l-selectin) | + | + |
| CD90 (Thy-1.2) | + | + |
| CD102 (ICAM-2) | + | + |
| CD106 (VCAM-1) | − | − |
| gp70 | + | + |
| αβTcR | + | + |
| TL | + | + |